{"result": "(\"entity\"<|>NUTRITIONAL SUPPORT<|>EVENT<|>Nutritional support is a medical intervention for patients, particularly in hematological contexts such as bone marrow transplants, to ensure adequate nutrition during recovery.)\n##\n(\"entity\"<|>HEMATOLOGICAL PATIENT<|>PERSON<|>A patient undergoing treatment for blood-related diseases, often requiring specialized nutritional support during recovery from procedures like bone marrow transplants.)\n##\n(\"entity\"<|>BONE MARROW TRANSPLANT<|>EVENT<|>A medical procedure where healthy bone marrow cells are infused into a patient to replace damaged or diseased bone marrow.)\n##\n(\"entity\"<|>GLUTAMINE<|>PERSON<|>Glutamine is a conditionally essential amino acid that plays a critical role in metabolic processes and is particularly important for patients in catabolic states.)\n##\n(\"relationship\"<|>HEMATOLOGICAL PATIENT<|>BONE MARROW TRANSPLANT<|>Hematological patients often undergo bone marrow transplants as part of their treatment for blood disorders.<|>8)\n##\n(\"relationship\"<|>NUTRITIONAL SUPPORT<|>BONE MARROW TRANSPLANT<|>Nutritional support is crucial for patients recovering from bone marrow transplants to ensure proper healing and recovery.<|>9)\n##\n(\"relationship\"<|>GLUTAMINE<|>HEMATOLOGICAL PATIENT<|>Glutamine is important for hematological patients as it helps in recovery and metabolic processes during their treatment.<|>7)\n##\n(\"relationship\"<|>NUTRITIONAL SUPPORT<|>GLUTAMINE<|>Nutritional support often includes glutamine to aid in the recovery of patients undergoing treatments like bone marrow transplants.<|>6)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: que limitaban su interpretación. Por ejemplo, incluían tanto niños como adultos, el grupo control no era adecuado y muchos enfermos cambiaban de brazo en el ensayo. En estudios posteriores se ha comprobado que la NP es una terapia nutricional segura, pero no exenta de complicaciones47.\n\nLa necesidad de NP varía en función del tipo de trasplante. Pocos casos requieren NP después del trasplante autólogo. Los nuevos regímenes de trasplante en los que se emplean factores de crecimiento y la realización de trasplante de sangre periférica han disminuido de forma significativa el tiempo necesario para el anidamiento del injerto y, paralelamente, el tiempo de ingesta oral insuficiente. En la actualidad, se requiere NP más frecuentemente en el trasplante alogénico, debido a la mayor toxicidad gastrointestinal por mucositis y diarrea y por el riesgo de EICH. Cuando se aplican los criterios de malnutrición severa la NP estaría indicada en el 37% de los trasplantes autólogos sin irradiación corporal total previa, en el 50% de los trasplantes autólogos con irradiación previa, en el 58% de los trasplantes alogénicos con irradiación previa y donante HLA compatible y en el 92% de los trasplantes alogénicos con irradiación previa y donante HLA no compatible42.\n\nLa composición de las bolsas de NP debe reflejar las recomendaciones nutricionales para estos enfermos que se han señalado anteriormente. En cualquier caso, la NP será prescrita de forma individualizada48 y siempre por personal sanitario experimentado para evitar efectos adversos y obtener los mejores resultados clínicos49.\n\nExiste controversia sobre el momento más adecuado para iniciar la NP. Algunos equipos la inician en el día 1 postrasplante y la mantienen hasta el día 15-20 y otros la inician cuando el paciente presenta alguna complicación digestiva. Cuando el paciente presente una mejoría de su capacidad digestiva, se debe ir disminuyendo progresivamente la cantidad de NP prescrita e ir aumentando los aportes por vía oral/enteral. Cuando el paciente cubra el 50% de sus requerimientos vía oral/enteral se suspenderá la NP42.\n\nEn cuanto a la forma de administración de la NP, si bien en la mayor parte de las ocasiones se administra en infusión continua a lo largo de 24 horas, parece que su administración cíclica facilita el tratamiento farmacológico, es segura y permite alcanzar un adecuado estado nutricional al finalizar la terapia50.\n\nPor último, hay que recordar que los pacientes sometidos a NP pueden presentar complicaciones secundarias a este tipo de soporte nutricional. Entre ellas destaca el riesgo de infección, que es especialmente alto en el trasplante de células hematopoyéticas, sobre todo durante la fase aplásica. Para evitarlo algunos autores han recomendado usar tipos específicos de catéteres (permanentes, impregnados con plata o impregnados con antibióticos) y extremar las medidas de asepsia en la colocación y manipulación del catéter. El factor que ha demostrado ser más importante en la prevención de la sepsis por catéter es la motivación del personal de enfermería para llevar a cabo un correcto cuidado de la vía venosa central. Otra complicación de la NP es la mayor tendencia a desarrollar hiperglucemia47. En algunos estudios se ha objetivado que en determinados grupos de enfermos, en especial pacientes críticos ingresados en Unidad de Cuidados Intensivos quirúrgica51, 52 el mantenimiento de la normoglucemia disminuye la morbimortalidad. En otros estudios53, 54 esto no se ha confirmado, y en cambio el control estricto se asociaba a mayor riesgo de hipoglucemia. En un estudio retrospectivo se observó un aumento continuo del riesgo de infección con cifras elevadas de glucemia anteriores al trasplante, especialmente en pacientes que recibieron glucocorticoides mientras estaban neutropénicos55. Para minimizar la hiperglucemia es preciso realizar un correcto cálculo de las necesidades energéticas antes del inicio de la terapia nutricional y administrar una dosis adecuada de hidratos de carbono e insulina.\n---\nTema 41. Soporte nutricional en el paciente hematológico (trasplante de médula ósea y enfermedad)...    667\n\n### 8.3. Glutamina\n\nLa glutamina es el aminoácido más abundante en el organismo, sobre todo en plasma y músculo esquelético. Es un aminoácido no esencial, que es considerado como «condicionalmente» esencial en ciertos estados catabólicos, ya que disminuye en enfermedades agudas y graves (sepsis, traumatismos, quemaduras) y sus concentraciones plasmáticas bajas se correlacionan inversamente con el pronóstico56. Es un sustrato fundamental en muchos procesos metabólicos, como son la transferencia\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}